Sharon Melamed

3.3k total citations · 2 hit papers
35 papers, 1.3k citations indexed

About

Sharon Melamed is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Sharon Melamed has authored 35 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 15 papers in Virology and 14 papers in Epidemiology. Recurrent topics in Sharon Melamed's work include Poxvirus research and outbreaks (15 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Herpesvirus Infections and Treatments (10 papers). Sharon Melamed is often cited by papers focused on Poxvirus research and outbreaks (15 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Herpesvirus Infections and Treatments (10 papers). Sharon Melamed collaborates with scholars based in Israel, United States and Russia. Sharon Melamed's co-authors include Nir Paran, Tomer Israely, Hagit Achdout, Hadas Tamir, Ofir Israeli, Noam Erez, Shay Weiss, Adi Beth-Din, Boaz Politi and Yfat Yahalom-Ronen and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Sharon Melamed

35 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The coding capacity of SARS-CoV-2

2020 382 citations Yaara Finkel, Orel Mizrahi et al. Nature profile →
Diagnosis of Imported Monkeypox, Israel, 2018

2019 302 citations Noam Erez, Hagit Achdout et al. Emerging infectious diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon Melamed Israel	16	609	534	520	504	173	35	1.3k
Tomer Israely Israel	19	741 1.2×	648 1.2×	511 1.0×	483 1.0×	284 1.6×	43	1.6k
Hadas Tamir Israel	10	625 1.0×	530 1.0×	346 0.7×	335 0.7×	175 1.0×	19	1.2k
Adi Beth-Din Israel	12	527 0.9×	371 0.7×	350 0.7×	293 0.6×	87 0.5×	36	972
Olivier Ferraris France	20	373 0.6×	349 0.7×	201 0.4×	812 1.6×	124 0.7×	57	1.2k
Ruben M. Markosyan United States	19	585 1.0×	624 1.2×	797 1.5×	549 1.1×	517 3.0×	24	1.7k
Rui Pedro Galão United Kingdom	17	383 0.6×	362 0.7×	330 0.6×	249 0.5×	395 2.3×	22	1.1k
Antonio Más Spain	21	347 0.6×	599 1.1×	527 1.0×	215 0.4×	84 0.5×	87	1.2k
Zhi Hong United States	22	815 1.3×	921 1.7×	309 0.6×	996 2.0×	157 0.9×	34	2.6k
Logan Banadyga Canada	18	264 0.4×	699 1.3×	207 0.4×	391 0.8×	139 0.8×	52	1.1k
Shihyun You United States	14	414 0.7×	434 0.8×	264 0.5×	466 0.9×	167 1.0×	21	1.4k

Countries citing papers authored by Sharon Melamed

Since Specialization

Citations

This map shows the geographic impact of Sharon Melamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Melamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Melamed more than expected).

Fields of papers citing papers by Sharon Melamed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Melamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Melamed. The network helps show where Sharon Melamed may publish in the future.

Co-authorship network of co-authors of Sharon Melamed

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Melamed. A scholar is included among the top collaborators of Sharon Melamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Melamed. Sharon Melamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tamir, Hadas, Tal Noy-Porat, Sharon Melamed, et al.. (2024). Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection. Nature Communications. 15(1). 3265–3265. 10 indexed citations

Yahalom-Ronen, Yfat, Hadas Tamir, Sharon Melamed, et al.. (2023). VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 Variants. Viruses. 15(6). 1364–1364. 2 indexed citations

Gutman, Hila, Moshe Aftalion, Sharon Melamed, et al.. (2022). Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice. Viruses. 14(8). 1627–1627. 11 indexed citations

Vitner, Einat B., Hagit Achdout, Roy Avraham, et al.. (2021). Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus. Journal of Biological Chemistry. 296. 100470–100470. 29 indexed citations

Achdout, Hagit, Einat B. Vitner, Boaz Politi, et al.. (2021). Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity. Nature Communications. 12(1). 5819–5819. 50 indexed citations

Achdout, Hagit, Orit Berhani, Einat B. Vitner, et al.. (2021). SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection. PLoS Pathogens. 17(12). e1010175–e1010175. 17 indexed citations

Melamed, Sharon, Boaz Politi, Ettie Grauer, et al.. (2021). Monitoring Group Activity of Hamsters and Mice as a Novel Tool to Evaluate COVID-19 Progression, Convalescence, and rVSV-ΔG-Spike Vaccination Efficacy. Frontiers in Bioengineering and Biotechnology. 9. 737627–737627. 1 indexed citations

Vitner, Einat B., Roy Avraham, Boaz Politi, Sharon Melamed, & Tomer Israely. (2021). Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology. Life Science Alliance. 5(1). e202101168–e202101168. 24 indexed citations

Finkel, Yaara, Orel Mizrahi, Aharon Nachshon, et al.. (2020). The coding capacity of SARS-CoV-2. Nature. 589(7840). 125–130. 382 indexed citations breakdown →

10.

Vagima, Yaron, David Gur, Noam Erez, et al.. (2020). Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments. Scientific Reports. 10(1). 19116–19116. 4 indexed citations

11.

Melamed, Sharon, Roy Avraham, Noam Erez, et al.. (2020). Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis. Acta Neuropathologica Communications. 8(1). 144–144. 9 indexed citations

12.

Vagima, Yaron, Ettie Grauer, Boaz Politi, et al.. (2020). Group activity of mice in communal home cage used as an indicator of disease progression and rate of recovery: Effects of LPS and influenza virus. Life Sciences. 258. 118214–118214. 3 indexed citations

13.

Cohen-Gihon, Inbar, Ofir Israeli, Ohad Shifman, et al.. (2020). Identification and Whole-Genome Sequencing of a Monkeypox Virus Strain Isolated in Israel. Microbiology Resource Announcements. 9(10). 33 indexed citations

14.

Erez, Noam, Hagit Achdout, Elad Milrot, et al.. (2019). Diagnosis of Imported Monkeypox, Israel, 2018. Emerging infectious diseases. 25(5). 980–983. 302 indexed citations breakdown →

15.

Melamed, Sharon, Tomer Israely, & Nir Paran. (2018). Challenges and Achievements in Prevention and Treatment of Smallpox. Vaccines. 6(1). 8–8. 32 indexed citations

16.

Achdout, Hagit, Shlomo Lustig, Tomer Israely, et al.. (2017). Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models. Vaccine. 35(33). 4245–4254. 9 indexed citations

17.

Israely, Tomer, Sharon Melamed, Hagit Achdout, et al.. (2014). TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines. PLoS ONE. 9(10). e110545–e110545. 15 indexed citations

18.

Paran, Nir, Shlomo Lustig, Anat Zvi, et al.. (2013). Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response. Virology Journal. 10(1). 229–229. 27 indexed citations

19.

Israely, Tomer, Nir Paran, Shlomo Lustig, et al.. (2012). A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease. Virology Journal. 9(1). 119–119. 18 indexed citations

20.

Lustig, Shlomo, Galia Maik-Rachline, Nir Paran, et al.. (2009). Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response. Vaccine. 27(11). 1691–1699. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact